-
Tytuł:
-
Single-pass albumin dialysis and hemoadsorption for bilirubin and bile acids removal for a child with hyperbilirubinemia after ventricular assist device implantation.
-
Autorzy:
-
Hui WF; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Doctor's Office, 9/F, Tower B, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong SAR. .
Lun KS; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Doctor's Office, 9/F, Tower B, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong SAR.
Hon KL; Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Doctor's Office, 9/F, Tower B, 1 Shing Cheong Road, Kowloon Bay, Kowloon, Hong Kong SAR. .
-
Źródło:
-
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs [J Artif Organs] 2022 Sep; Vol. 25 (3), pp. 270-273. Date of Electronic Publication: 2022 Jan 17.
-
Typ publikacji:
-
Case Reports; Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Original Publication: Tokyo : Springer Verlag, c1998-
-
MeSH Terms:
-
Bilirubin*
Heart-Assist Devices*
Adolescent ; Albumins ; Bile Acids and Salts ; Child ; Humans ; Hyperbilirubinemia ; Male ; Renal Dialysis
-
References:
-
Majumder K, Spratt JR, Holley CT, Roy SS, Cogswell RJ, Liao K, John R. Impact of postoperative liver dysfunction on survival after left ventricular assist device implantation. Ann Thorac Surg. 2017;104:1556–62. (PMID: 10.1016/j.athoracsur.2017.04.048)
Yang JA, Kato TS, Shulman BP, Takayama H, Farr M, Jorde UP, Mancini DM, Naka Y, Schulze PC. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. J Heart Lung Transplant. 2012;31:601–10. (PMID: 10.1016/j.healun.2012.02.027)
Wadia Y, Etheridge W, Smart F, Wood RP, Frazier OH. Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support. J Heart Lung Transplant. 2005;24:361–70. (PMID: 10.1016/j.healun.2004.09.012)
Hui WF, Hon KL, Leung AK, Leung KKY, Ku SW, Cheng FW. Continuous renal replacement therapy (CRRT) for nonrenal indications among critically ill children with malignancy. Case Reports Pediatrics. 2021. https://doi.org/10.1155/2021/6660466 . (PMID: 10.1155/2021/6660466)
Piwowarczyk P, Kutnik P, Potręć-Studzińska B, Sysiak-Sławecka J, Rypulak E, Borys M, Czczuwar M. Hemoadsorption in isolated conjugated hyperbilirubinemia after extracorporeal membrane oxygenation support. Cholestasis of sepsis: A case report and review of the literature on differential causes of jaundice in ICU patient. Int J Artif Organs. 2019;42:263–8. (PMID: 10.1177/0391398819834012)
Rainer PP, Primessnig U, Harenkamp S, Doleschal B, Wallner M, Fauler G, Stojakovic T, Wachter R, Yates A, Groschner K, Trauner M, Pieske BM, von Lewinski D. Bile acids induce arrhythmias in human atrial myocardium–implications for altered serum bile acid composition in patients with atrial fibrillation. Heart. 2013;99:1685–92. (PMID: 10.1136/heartjnl-2013-304163)
Horvatits T, Drolz A, Rutter K, Roedl K, Langouche L, Van den Berghe G, Fauler G, Meyer B, Hülsmann M, Heinz G, Trauner M, Fuhrmann V. Circulating bile acids predict outcome in critically ill patients. Ann Intensive Care. 2017:48. (PMID: 10.1186/s13613-017-0272-7)
Alshamsi F, Alshammari K, Belley-Cote E, Dionne J, Albrahim T, Albudoor B, Ismail M, Al-Judaibi B, Baw B, Subramanian RM, Steadman R, Galusca D, Huang DT, Nanchal R, Al Quraini M, Yuan Y, GUIDE Group. Alhazzani W Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med. 2020;46:1–16. (PMID: 10.1007/s00134-019-05783-y)
Ankawi G, Xie Y, Yang B, Xie Y, Xie P, Ronco C. What have we learned about the use of cytosorb adsorption columns? Blood Purif. 2019;48:196–202. (PMID: 10.1159/000500013)
Gemelli C, Cuoghi A, Magnani S, Atti M, Ricci D, Siniscalchi A, Mancini E, Faenza S. Removal of bilirubin with a new adsorbent system: In vitro kinetics. Blood Purif. 2019;47:10–5. (PMID: 10.1159/000492378)
Dominik A, Stange J. Similarities, differences, and potential synergies in the mechanism of action of albumin dialysis using the MARS albumin dialysis device and the CytoSorb hemoperfusion device in the treatment of liver failure. Blood Purif. 2021;50:119–28. (PMID: 10.1159/000508810)
Schmuck RB, Nawrot GH, Fikatas P, Reutzel-Selke A, Pratschke J, Sauer IM. Single pass albumin dialysis - A dose-finding study to define optimal albumin concentration and dialysate flow. Artif Organs. 2017;41:153–61. (PMID: 10.1111/aor.12736)
Scharf C, Liebchen U, Paal M, Becker-Pennrich A, Irlbeck M, Zoller M, Schroeder I. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study. Sci Rep. 2021;11:10190. (PMID: 10.1038/s41598-021-89712-4)
-
Contributed Indexing:
-
Keywords: Children; Hemoadsorption; Hyperbilirubinemia; Single-pass albumin dialysis; Ventricular assist device
-
Substance Nomenclature:
-
0 (Albumins)
0 (Bile Acids and Salts)
RFM9X3LJ49 (Bilirubin)
-
Entry Date(s):
-
Date Created: 20220117 Date Completed: 20220830 Latest Revision: 20220830
-
Update Code:
-
20240105
-
DOI:
-
10.1007/s10047-022-01309-4
-
PMID:
-
35038050
-
We report the successful management of hyperbilirubinemia using two different modalities of extracorporeal bilirubin removal therapy for a pediatric patient. A 13-year-old boy with dilated cardiomyopathy requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) developed acute kidney injury and was dependent on continuous renal replacement therapy. He developed hyperbilirubinemia with a peak total bilirubin level of 786 μmol/L after implantation of biventricular assist device (BiVAD). Extracorporeal bilirubin and bile acids removal using single-pass albumin dialysis (SPAD) with 4% albumin as dialysate brought down the bilirubin level to 672 μmol/L after 21 h of therapy. Subsequently, he was started on two sessions of hemoadsorption using the Cytosorb® column which further lowered the total bilirubin level to 306 μmol/ in 24 h and 173 μmol/ after the treatment. No complication was encountered. Our case illustrated that both SPAD and hemoadsorption can effectively and safely reduce the serum bilirubin and bile acid levels in pediatric patients with BiVAD implantation. The ease of set-up, faster rate of bilirubin decline and capability of cytokine removal make hemoadsorption a favorable alternative to albumin dialysis.
(© 2022. The Japanese Society for Artificial Organs.)